Skip to main content
Quest Diagnostics

Diagnostic Stewardship Around Antimicrobial Susceptibility Testing - Are We ‘Gatekeeping’ or ‘Gate breaking’?

ASM-CMO 2026

American Sodiety for Microbiology - Clin Micro Open (CMO)

Del Mar, CA, Feb 4-6, 2026

Oral presentation: Diagnostic Stewardship Around Antimicrobial Susceptibility Testing - Are We ‘Gatekeeping’ or ‘Gate breaking’?

Authors: Uprety P

Medical Specialty: Laboratory Medicine, Infectious disease

Related content

Audio Podcast
The power of laboratory analytics
Publication
Increased Odds of Antibiotic Resistance in E. coli Isolates from Recurrent Urinary Tract Infections
Conference Presentation
Rapid Antimicrobial Susceptibility Testing (rAST) Directly from Positive Blood Cultures, A Pilot Study on ASTar Platform (Q-Linea)
Publication
Multicenter Evaluation of the eQUANT System for Use With Disk Diffusion AST of Gram-Negative Bacteria Directly From Positive Blood Cultures
Publication
Cluster of Extensively Drug-Resistant Shigella sonnei Carrying blaCTX-M-15 in Los Angeles, California, 2023 to 2024.
Test FAQ
Carbapenem Resistant Enterobacteriaceae Culture Screen

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.